The Lucknow bench of Allahabad high court on Wednesday expressed dissatisfaction with the Central Bureau of Investigation probe into the murder of two chief medical officers in Lucknow and said that nothing substantial was done in the last two-three months.
The observation was made by a division bench of Justice Imtiyaz Murtaza and Justice Ashwani Kumar Singh while hearing a PIL on the CBI probe into alleged scam in CMO office Lucknow and murder of two CMOs V K Arya and B P Singh.
"Nothing substantial has been done in the last two-three months by the CBI in the investigation of these cases," the court observed after the investigating officers of the CBI submitted a sealed status report on the probe into murder of two CMOs.
The court directed the Superintendent of Police of CBI along with the two investigating officers to appear in person on the next date of hearing on September 12.
On behalf of the state government, Additional Advocate General Raj Bahadur Singh Yadav submitted order of prosecution sanction against 34 health department employees, including doctors.
Earlier on Thursday last, the state government gave an undertaking in the court to take a decision on prosecution sanction against 34 public servants allegedly involved in NRHM scam at Lucknow chief medical officer office by August 29.
Principal secretary medical and health Sanjay Agarwal gave the undertaking before the bench of Justice Imtiyaz Murtaza and Justice Ashwani Kumar Singh after he was summoned for personal appearance.
Following the undertaking by the government the court had fixed August 29 as the next date of hearing.
The CBI also filed an affidavit that it would take 30 days to complete investigation into alleged irregularities in procurement of medicines at CMO office Lucknow.
Earlier, the CBI pleaded before the court that prosecution sanction of 34 doctors and other staff, including former CMO Lucknow A K Shukla was pending with the government since May this year.
The court had directed the CBI to submit progress report in the murder cases of two CMOs on the next date of hearing.
